• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis

by MM360 Staff | Jul 17, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy

by MM360 Staff | Jul 15, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Incidence and prevalence of light chain amyloidosis in the United States in 2019–2021 using Optum EHR data

by MM360 Staff | Jul 12, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Interleukin-6 is a highly prognostic biomarker for POEMS syndrome

by MM360 Staff | Jul 12, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Targeting proteostasis in multiple myeloma through inhibition of LTK

by MM360 Staff | Jul 9, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

by MM360 Staff | Jul 9, 2025 | Myeloma News

Source: Pharmacy Times articles New data reveals isatuximab-based therapy achieves high MRD-negativity rates in newly diagnosed multiple myeloma. Read More
« Older Entries
Next Entries »

Recent Content

  • Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
  • Carvykti label updated to include survival benefit data in myeloma
  • Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis
  • FDA approves ziftomenib to treat some relapsed leukemia patients
  • (no title)
  • The challenge of non-transplant eligible, newly diagnosed multiple myeloma
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Tinostamustine named orphan drug for treating malignant gliomas
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT